188 related articles for article (PubMed ID: 30811587)
1. Multistakeholder Advice at the European Medicines Agency: Is It Still Needed?
Vamvakas S; Moseley J; Vetter T
Clin Pharmacol Ther; 2019 Apr; 105(4):819-821. PubMed ID: 30811587
[No Abstract] [Full Text] [Related]
2. Engaging patients in medicines regulation: a tale of two agencies.
Mavris M; Furia Helms A; Bere N
Nat Rev Drug Discov; 2019 Nov; 18(12):885-886. PubMed ID: 31780842
[No Abstract] [Full Text] [Related]
3. Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products.
Ceci A; Felisi M; Catapano M; Baiardi P; Cipollina L; Ravera S; Bagnulo S; Reggio S; Rondini G
Eur J Clin Pharmacol; 2002 Nov; 58(8):495-500. PubMed ID: 12451425
[TBL] [Abstract][Full Text] [Related]
4. European investigational antiepilepsy drug trials.
Sussman NM
Epilepsy Res Suppl; 1993; 10():149-55. PubMed ID: 8251090
[No Abstract] [Full Text] [Related]
5. The EMEA guideline on first-in-human clinical trials and its impact on pharmaceutical development.
Milton MN; Horvath CJ
Toxicol Pathol; 2009 Apr; 37(3):363-71. PubMed ID: 19246571
[No Abstract] [Full Text] [Related]
6. European Medicines Agency-Health Technology Assessment Parallel Consultation Platform: An Industry Perspective.
Khan S; Carter M
Clin Pharmacol Ther; 2019 Apr; 105(4):822-825. PubMed ID: 30811582
[No Abstract] [Full Text] [Related]
7. Are the European Medicines Agency, US Food and Drug Administration, and Other International Regulators Talking to Each Other?
Teixeira T; Kweder SL; Saint-Raymond A
Clin Pharmacol Ther; 2020 Mar; 107(3):507-513. PubMed ID: 31449664
[TBL] [Abstract][Full Text] [Related]
8. European Medicines Agency pledges to publish clinical reports.
Watson R
BMJ; 2014 Oct; 349():g6086. PubMed ID: 25294699
[No Abstract] [Full Text] [Related]
9. Regulatory policies on medicines for psychiatric disorders: is Europe on target?
Barbui C; Garattini S
Br J Psychiatry; 2007 Feb; 190():91-3. PubMed ID: 17267922
[TBL] [Abstract][Full Text] [Related]
10. Moment of reckoning.
Wadman M
Nature; 2007 Apr; 446(7138):844-5. PubMed ID: 17443154
[No Abstract] [Full Text] [Related]
11. The FDA Amendments Act of 2007 - Assessing Its Effects a Decade Later.
Avorn J; Kesselheim A; Sarpatwari A
N Engl J Med; 2018 Sep; 379(12):1097-1099. PubMed ID: 30231220
[No Abstract] [Full Text] [Related]
12. FDA and drug approval.
Faich GA
J Vasc Interv Radiol; 1995; 6(6 Pt 2 Suppl):24S. PubMed ID: 8770838
[No Abstract] [Full Text] [Related]
13. Progress and deficiencies in the registration of clinical trials.
Wood AJ
N Engl J Med; 2009 Feb; 360(8):824-30. PubMed ID: 19228628
[No Abstract] [Full Text] [Related]
14. Regulatory issues with multiplicity in drug approval: Principles and controversies in a changing landscape.
Benda N; Brandt A
J Biopharm Stat; 2018; 28(1):3-9. PubMed ID: 29065277
[TBL] [Abstract][Full Text] [Related]
15. Regulatory watch: Impact of scientific advice from the European Medicines Agency.
Hofer MP; Jakobsson C; Zafiropoulos N; Vamvakas S; Vetter T; Regnstrom J; Hemmings RJ
Nat Rev Drug Discov; 2015 May; 14(5):302-3. PubMed ID: 25881970
[No Abstract] [Full Text] [Related]
16. Regulatory science as a bridge between science and society.
Tominaga T; Asahina Y; Uyama Y; Kondo T
Clin Pharmacol Ther; 2011 Jul; 90(1):29-31. PubMed ID: 21691273
[TBL] [Abstract][Full Text] [Related]
17. Clinical trials performed for the new drug approval process in the United States: standard methods and alternative methods.
Browne TR
Epilepsy Res Suppl; 1993; 10():31-44. PubMed ID: 8251105
[No Abstract] [Full Text] [Related]
18. A Comparison of EMA and FDA Decisions for New Drug Marketing Applications 2014-2016: Concordance, Discordance, and Why.
Kashoki M; Hanaizi Z; Yordanova S; Veselý R; Bouygues C; Llinares J; Kweder SL
Clin Pharmacol Ther; 2020 Jan; 107(1):195-202. PubMed ID: 31306483
[TBL] [Abstract][Full Text] [Related]
19. Overview of the European Medicines Agency's Development of Product-Specific Bioequivalence Guidelines.
Sullivan JO; Blake K; Berntgen M; Salmonson T; Welink J;
Clin Pharmacol Ther; 2018 Sep; 104(3):539-545. PubMed ID: 29319156
[TBL] [Abstract][Full Text] [Related]
20. Trouble at the office.
Allison M
Nat Biotechnol; 2008 Sep; 26(9):967-9. PubMed ID: 18779797
[No Abstract] [Full Text] [Related]
[Next] [New Search]
